[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SentinelFlash Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1873821816604565505.png) StockSentinel [@SentinelFlash](/creator/twitter/SentinelFlash) on x XX followers
Created: 2025-07-23 23:46:11 UTC

$RIGL: Rigel Pharmaceuticals just posted its first annual profit, fueled by three FDA-approved drugs and strong global partnerships. With a lean balance sheet, modest valuation, and double-digit revenue growth, upside remains if execution continues. Risks are manageable, but competition is fierce. Is this specialty pharma turnaround built to last?


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948167793435722076/c:line.svg)

**Related Topics**
[quarterly earnings](/topic/quarterly-earnings)
[balance sheet](/topic/balance-sheet)
[$rigl](/topic/$rigl)

[Post Link](https://x.com/SentinelFlash/status/1948167793435722076)